Mapping the differences in the brain concentration of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in an animal model of depression

NeuroReport

Volumn 11, Issue 6, 2000, Pages 1369-1373

  Angelucci, Francesco ^a   Aloe, Luigi ^b   Vasquez, Patricia Jiménez ^a   Mathé, Aleksander A ^a  

^a ST GÖRAN S HOSPITAL   (Sweden)

^b CNR   (Italy)

Author keywords

BDNF; Brain; Depression; Flinders sensitive line; NGF; Rat

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEUROTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MAPPING; CELL SURVIVAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; GABAERGIC TRANSMISSION; MOUSE; NERVE CELL PLASTICITY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STIMULUS RESPONSE;

EID: 0034720257     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200004270-00044     Document Type: Article

References (21)

1. 1. Nibuya M, Morinobu S and Duman R. J Neurosci 15, 7539-7547 (1995).
2. 2. Thoenen H. Science 270, 593-598 (1995).
3. 3. Kokaia Z, Gido G, Ringstedt T et al. Brain Res Mol Brain Res 19, 277-286 (1993).
4. 4. Herrera DG, Maysinger D, Gadient R et al. Brain Res 602, 99-103 (1993).
5. 5. Suciak JA, Lewis DR, Wiegand SJ et al. Pharmacol Biochem Behav 56, 131-137 (1997).
6. 6. Aloe L, Bracci-Laudiero L, Alleva E et al. Proc Natl Acad Sci USA 91, 10440-10444 (1994).
7. 7. Ueyama T, Kawai Y, Nemoto K et al. Neurosci Res 28, 103-110 (1997).
8. 8. Weissman MM and Olfson M. Science 269, 799-801 (1995).
9. 9. Overstreet DH, Russell RW, Helps SC et al. Psychopharmacology 65, 15-20 (1979).
10. 10. Overstreet DH. Neurosci Biobehav Rev 17, 51-68 (1993).
11. 11. Overstreet DH, Pucilowski O, Rezvani AH et al. Psychopharmacology 121, 27-37 (1995).
12. 12. Weskamp G and Otten U. J Neurochem. 48, 1779-1786 (1986).
13. 13. Angelucci F, Aloe L, Gruber SH and Mathé A. Int J Neuropsychopharmacol 3, (in press) (2000).
14. 14. Aloe L, Properzi F, Probert L et al. Brain Res 840, 125-137 (1999).
15. 15. Bracci-Laudiero L, Aloe L, Levi Montalcini R et al. Neurosci Lett 147, 9-12 (1992).
16. 16. Nawa H, Carnahan J and Gall C. Eur J Neurosci 7, 1527-1535 (1995).
17. 17. Altar CA. Trends Pharm Sci 20, 59-61 (1999).
18. 18. Duman RS, Vaidya VA, Nibuya M et al. Neuroscientist 1, 351-360 (1995).
19. 19. Duman RS, Heninger GR and Nestler EJ. Arch Gen Psychiatry 54, 597-606 (1997).
20. 20. De Vries GJ. J Neuroendocrinol 2, 1-12 (1990).
21. 21. Maier W, Gansicke M, Gater R et al. J Affect Disord 53, 241-52 (1999).